Nurix Therapeutics, Inc. (NRIX)
NASDAQ: NRIX · Real-Time Price · USD
9.18
-0.54 (-5.56%)
Oct 14, 2025, 4:00 PM EDT - Market closed

Nurix Therapeutics Income Statement

Millions USD. Fiscal year is Dec - Nov.
Fiscal Year
TTMFY 2024FY 2023FY 2022FY 2021FY 20202018 - 2019
Period Ending
Aug '25 Nov '24 Nov '23 Nov '22 Nov '21 Nov '20 2018 - 2019
83.6954.5576.9938.6329.7517.82
Upgrade
Revenue Growth (YoY)
48.32%-29.14%99.31%29.84%66.95%-42.73%
Upgrade
Cost of Revenue
301.1221.63189.15184.5116.4366.49
Upgrade
Gross Profit
-217.42-167.08-112.16-145.87-86.68-48.67
Upgrade
Selling, General & Admin
49.8145.9442.93831.216.31
Upgrade
Operating Expenses
49.8145.9442.93831.216.31
Upgrade
Operating Income
-267.23-213.03-155.06-183.87-117.89-64.98
Upgrade
Interest & Investment Income
23.2119.7311.123.510.821.21
Upgrade
Pretax Income
-244.02-193.3-143.95-180.36-117.06-63.78
Upgrade
Income Tax Expense
0.770.27--0.13-20.54
Upgrade
Net Income
-244.79-193.57-143.95-180.36-117.19-43.24
Upgrade
Net Income to Common
-244.79-193.57-143.95-180.36-117.19-43.24
Upgrade
Shares Outstanding (Basic)
826754494316
Upgrade
Shares Outstanding (Diluted)
826754494316
Upgrade
Shares Change (YoY)
34.77%23.52%11.79%13.32%173.68%376.03%
Upgrade
EPS (Basic)
-2.97-2.88-2.65-3.71-2.73-2.76
Upgrade
EPS (Diluted)
-2.97-2.88-2.65-3.71-2.73-2.76
Upgrade
Free Cash Flow
-241.36-181.86-89.77-172.05-90.03-4.63
Upgrade
Free Cash Flow Per Share
-2.93-2.71-1.65-3.54-2.10-0.30
Upgrade
Gross Margin
-259.80%--145.69%--291.38%-273.14%
Upgrade
Operating Margin
-319.32%-390.52%-201.41%-476.01%-396.25%-364.66%
Upgrade
Profit Margin
-292.50%-354.85%-186.98%-466.93%-393.93%-242.66%
Upgrade
Free Cash Flow Margin
-288.41%-333.38%-116.60%-445.42%-302.61%-26.00%
Upgrade
EBITDA
-259.36-205.01-148.93-179.72-115.9-62.8
Upgrade
EBITDA Margin
---193.45%---
Upgrade
D&A For EBITDA
7.878.026.134.151.992.18
Upgrade
EBIT
-267.23-213.03-155.06-183.87-117.89-64.98
Upgrade
EBIT Margin
---201.41%---
Upgrade
Revenue as Reported
83.6954.5576.9938.63--
Upgrade
Updated Oct 9, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.
SEC Filings: 10-K · 10-Q